nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—ADRA2A—Metabolism—CYP2A6—esophageal cancer	0.000433	0.000433	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000432	0.000432	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000432	0.000432	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—XIAP—esophageal cancer	0.00043	0.00043	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CYP1B1—esophageal cancer	0.00043	0.00043	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000425	0.000425	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—NOS3—esophageal cancer	0.000424	0.000424	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOTCH2—esophageal cancer	0.000423	0.000423	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.000421	0.000421	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000421	0.000421	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—KDR—esophageal cancer	0.000419	0.000419	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000418	0.000418	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PSME1—esophageal cancer	0.000416	0.000416	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PSME2—esophageal cancer	0.000416	0.000416	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—XIAP—esophageal cancer	0.000414	0.000414	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ANXA1—esophageal cancer	0.000414	0.000414	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000414	0.000414	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	0.000411	0.000411	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS1—esophageal cancer	0.00041	0.00041	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ENO1—esophageal cancer	0.00041	0.00041	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PSME2—esophageal cancer	0.00041	0.00041	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PSME1—esophageal cancer	0.00041	0.00041	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ANXA1—esophageal cancer	0.000408	0.000408	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNA1—esophageal cancer	0.000407	0.000407	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PSME2—esophageal cancer	0.000404	0.000404	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PSME1—esophageal cancer	0.000404	0.000404	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL2—esophageal cancer	0.000404	0.000404	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CYP19A1—esophageal cancer	0.000404	0.000404	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SST—esophageal cancer	0.000403	0.000403	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—EP300—esophageal cancer	0.000397	0.000397	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SST—esophageal cancer	0.000397	0.000397	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NOTCH1—esophageal cancer	0.000394	0.000394	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000393	0.000393	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—GHRL—esophageal cancer	0.000393	0.000393	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNA1—esophageal cancer	0.000392	0.000392	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL2—esophageal cancer	0.00039	0.00039	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000387	0.000387	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—GHRL—esophageal cancer	0.000387	0.000387	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FBXW7—esophageal cancer	0.000386	0.000386	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	0.000385	0.000385	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FBXW7—esophageal cancer	0.00038	0.00038	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PSME2—esophageal cancer	0.000378	0.000378	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PSME1—esophageal cancer	0.000378	0.000378	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000377	0.000377	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ANXA1—esophageal cancer	0.000376	0.000376	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFBR2—esophageal cancer	0.000376	0.000376	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFBR2—esophageal cancer	0.000371	0.000371	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—HMOX1—esophageal cancer	0.000369	0.000369	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SST—esophageal cancer	0.000366	0.000366	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000364	0.000364	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PSME2—esophageal cancer	0.000364	0.000364	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PSME1—esophageal cancer	0.000364	0.000364	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ANXA1—esophageal cancer	0.000362	0.000362	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	0.000362	0.000362	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CREBBP—esophageal cancer	0.000358	0.000358	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—GHRL—esophageal cancer	0.000356	0.000356	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOTCH3—esophageal cancer	0.000356	0.000356	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SMAD4—esophageal cancer	0.000356	0.000356	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ABCB1—esophageal cancer	0.000354	0.000354	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SST—esophageal cancer	0.000352	0.000352	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOTCH2—esophageal cancer	0.000352	0.000352	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—EGFR—esophageal cancer	0.000351	0.000351	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SMAD4—esophageal cancer	0.000351	0.000351	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FBXW7—esophageal cancer	0.000351	0.000351	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CYP1B1—esophageal cancer	0.000349	0.000349	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000347	0.000347	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—GHRL—esophageal cancer	0.000343	0.000343	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000343	0.000343	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	0.000338	0.000338	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	0.000338	0.000338	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FBXW7—esophageal cancer	0.000338	0.000338	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000337	0.000337	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000336	0.000336	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000335	0.000335	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CYP19A1—esophageal cancer	0.000328	0.000328	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SST—esophageal cancer	0.000327	0.000327	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—EP300—esophageal cancer	0.000323	0.000323	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NOS3—esophageal cancer	0.00032	0.00032	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOTCH2—esophageal cancer	0.00032	0.00032	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000319	0.000319	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	0.000319	0.000319	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000317	0.000317	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	0.000315	0.000315	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	0.000314	0.000314	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	0.000313	0.000313	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000308	0.000308	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000308	0.000308	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—PIK3CA—esophageal cancer	0.000305	0.000305	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TP53—esophageal cancer	0.000304	0.000304	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—ERBB2—esophageal cancer	0.0003	0.0003	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—HMOX1—esophageal cancer	0.000299	0.000299	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	0.000296	0.000296	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	0.000294	0.000294	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SMAD4—esophageal cancer	0.000291	0.000291	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HIF1A—esophageal cancer	0.000291	0.000291	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ABCB1—esophageal cancer	0.000287	0.000287	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HIF1A—esophageal cancer	0.000287	0.000287	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000286	0.000286	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TP53—esophageal cancer	0.000284	0.000284	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFBR2—esophageal cancer	0.000284	0.000284	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KDR—esophageal cancer	0.000278	0.000278	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KDR—esophageal cancer	0.000275	0.000275	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000273	0.000273	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SMAD4—esophageal cancer	0.000268	0.000268	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCND1—esophageal cancer	0.000265	0.000265	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOTCH1—esophageal cancer	0.000262	0.000262	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	0.000259	0.000259	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	0.000259	0.000259	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOTCH1—esophageal cancer	0.000259	0.000259	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CDKN1A—esophageal cancer	0.000256	0.000256	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000254	0.000254	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KDR—esophageal cancer	0.000248	0.000248	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EP300—esophageal cancer	0.000244	0.000244	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	0.000242	0.000242	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	0.00024	0.00024	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	0.000239	0.000239	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HIF1A—esophageal cancer	0.000238	0.000238	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CREBBP—esophageal cancer	0.000238	0.000238	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CREBBP—esophageal cancer	0.000236	0.000236	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CREBBP—esophageal cancer	0.000234	0.000234	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—EGFR—esophageal cancer	0.000234	0.000234	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000233	0.000233	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KDR—esophageal cancer	0.000232	0.000232	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—esophageal cancer	0.000231	0.000231	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—EGFR—esophageal cancer	0.00023	0.00023	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KDR—esophageal cancer	0.000228	0.000228	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000223	0.000223	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00022	0.00022	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HIF1A—esophageal cancer	0.00022	0.00022	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	0.000218	0.000218	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOTCH1—esophageal cancer	0.000215	0.000215	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOS3—esophageal cancer	0.000213	0.000213	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MYC—esophageal cancer	0.000212	0.000212	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—NOS3—esophageal cancer	0.000212	0.000212	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	0.000212	0.000212	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	0.000212	0.000212	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KDR—esophageal cancer	0.00021	0.00021	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOS3—esophageal cancer	0.00021	0.00021	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	0.000208	0.000208	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EGFR—esophageal cancer	0.000208	0.000208	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000203	0.000203	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KDR—esophageal cancer	0.000202	0.000202	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PIK3CA—esophageal cancer	0.0002	0.0002	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ERBB2—esophageal cancer	0.000199	0.000199	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000199	0.000199	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	0.000198	0.000198	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	0.000198	0.000198	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	0.000197	0.000197	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ERBB2—esophageal cancer	0.000196	0.000196	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CREBBP—esophageal cancer	0.000195	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	0.000194	0.000194	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—esophageal cancer	0.000194	0.000194	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CREBBP—esophageal cancer	0.000192	0.000192	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—esophageal cancer	0.000191	0.000191	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	0.000191	0.000191	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	0.00019	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KDR—esophageal cancer	0.000188	0.000188	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000186	0.000186	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000183	0.000183	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000181	0.000181	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CA—esophageal cancer	0.00018	0.00018	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CREBBP—esophageal cancer	0.000179	0.000179	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	0.000177	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	0.000177	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	0.000177	0.000177	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—esophageal cancer	0.000176	0.000176	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCND1—esophageal cancer	0.000176	0.000176	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—esophageal cancer	0.000174	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	0.000174	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	0.000173	0.000173	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	0.000173	0.000173	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—esophageal cancer	0.000172	0.000172	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	0.00017	0.00017	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	0.00017	0.00017	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	0.000169	0.000169	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000169	0.000169	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	0.000168	0.000168	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000166	0.000166	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	0.000166	0.000166	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	0.000163	0.000163	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000162	0.000162	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EP300—esophageal cancer	0.000162	0.000162	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—EP300—esophageal cancer	0.000161	0.000161	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—esophageal cancer	0.000161	0.000161	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	0.000161	0.000161	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EP300—esophageal cancer	0.00016	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	0.000158	0.000158	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—esophageal cancer	0.000157	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	0.000157	0.000157	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	0.000155	0.000155	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000153	0.000153	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	0.000152	0.000152	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000151	0.000151	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—esophageal cancer	0.00015	0.00015	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000147	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	0.000146	0.000146	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	0.000145	0.000145	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EP300—esophageal cancer	0.000144	0.000144	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	0.000144	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	0.000144	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	0.000142	0.000142	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—esophageal cancer	0.000141	0.000141	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	0.000139	0.000139	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—esophageal cancer	0.000139	0.000139	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—esophageal cancer	0.000138	0.000138	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000137	0.000137	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	0.000136	0.000136	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EP300—esophageal cancer	0.000135	0.000135	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	0.000135	0.000135	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—esophageal cancer	0.000133	0.000133	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EP300—esophageal cancer	0.000133	0.000133	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—EP300—esophageal cancer	0.000131	0.000131	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	0.000128	0.000128	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	0.000128	0.000128	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—esophageal cancer	0.000126	0.000126	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	0.000124	0.000124	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	0.000123	0.000123	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EP300—esophageal cancer	0.000122	0.000122	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	0.00012	0.00012	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—esophageal cancer	0.000119	0.000119	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	0.000119	0.000119	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	0.000118	0.000118	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EP300—esophageal cancer	0.000118	0.000118	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—esophageal cancer	0.000117	0.000117	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—esophageal cancer	0.000116	0.000116	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—esophageal cancer	0.000116	0.000116	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	0.000115	0.000115	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	0.000115	0.000115	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—esophageal cancer	0.000114	0.000114	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	0.000113	0.000113	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EP300—esophageal cancer	0.000109	0.000109	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	0.000107	0.000107	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—esophageal cancer	0.000106	0.000106	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—esophageal cancer	0.000104	0.000104	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—esophageal cancer	0.000103	0.000103	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—esophageal cancer	0.000103	0.000103	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	0.0001	0.0001	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	9.96e-05	9.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	9.81e-05	9.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—esophageal cancer	9.68e-05	9.68e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—esophageal cancer	9.64e-05	9.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—esophageal cancer	9.53e-05	9.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—esophageal cancer	9.49e-05	9.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	9.32e-05	9.32e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	9.04e-05	9.04e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—esophageal cancer	8.75e-05	8.75e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	8.71e-05	8.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—esophageal cancer	8.43e-05	8.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	8.09e-05	8.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—esophageal cancer	7.83e-05	7.83e-05	CbGpPWpGaD
